Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.80 |
| ▸ | HSD11B1 | P28845 | 6/20 | 0.69 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | CNR2 | P34972 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8749262 | 1.00 | MAPK1 (0.80) | MAPK1HSD11B1L3MBTL1LMNAALDH1A1 | |
| SCHEMBL8749301 | 0.98 | MAPK1 (0.77) | MAPK1HSD11B1L3MBTL1LMNAALDH1A1 | |
| SCHEMBL8749177 | 0.98 | MAPK1 (0.77) | MAPK1HSD11B1L3MBTL1LMNAALDH1A1 | |
| SCHEMBL8748863 | 0.98 | MAPK1 (0.77) | MAPK1HSD11B1L3MBTL1LMNAALDH1A1 | |
| SCHEMBL8749263 | 0.98 | MAPK1 (0.77) | MAPK1HSD11B1L3MBTL1LMNAALDH1A1 | |
| SCHEMBL6881683 | 0.98 | MAPK1 (0.77) | MAPK1HSD11B1L3MBTL1LMNAALDH1A1 | |
| SCHEMBL8749079 | 0.98 | MAPK1 (0.77) | MAPK1HSD11B1L3MBTL1LMNAALDH1A1 | |
| SCHEMBL6870643 | 0.98 | MAPK1 (0.77) | MAPK1HSD11B1L3MBTL1LMNAALDH1A1 | |
| SCHEMBL29860741 | 0.92 | MAPK1 (0.73) | MAPK1HSD11B1L3MBTL1LMNAALDH1A1 | |
| SCHEMBL8749195 | 0.91 | MAPK1 (0.68) | MAPK1HSD11B1L3MBTL1LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220111367-A1 | HYDROGENATION CATALYST FOR USE IN HYDROGENATING AMIDE COMPOUND AND METHOD FOR PRODUCING AMINE COMPOUND USING SAME | OSAKA UNIVERSITY (JP) | 2022-04-14 | — | — | US | disclosed |
| US-9883997-B2 | Cosmetic compositions with tricyclodecane amides | CONOPCO, INC. (US) | 2018-02-06 | — | — | US | disclosed |
| US-9883997-B2 | Cosmetic compositions with tricyclodecane amides | CONOPCO, INC. (US) | 2018-02-06 | — | — | US | disclosed |
| US-9840466-B2 | Process of making adamantanamides | CONOPCO, INC. (US) | 2017-12-12 | — | — | US | disclosed |
| US-9840466-B2 | Process of making adamantanamides | CONOPCO, INC. (US) | 2017-12-12 | — | — | US | disclosed |
| EP-2969026-B1 | COSMETIC COMPOSITIONS WITH TRICYCLODECANE AMIDES | UNILEVER PLC (GB) | 2017-11-01 | — | — | EP | disclosed |
| US-9775793-B2 | Prolonged delivery of certain fragrance components from personal care compositions | CONOPCO, INC. (US) | 2017-10-03 | — | — | US | disclosed |
| US-9775793-B2 | Prolonged delivery of certain fragrance components from personal care compositions | CONOPCO, INC. (US) | 2017-10-03 | — | — | US | disclosed |
| EP-3080086-B1 | PROCESS OF MAKING ADAMANTANAMIDES | UNILEVER PLC A COMPANY REGISTERED IN ENGLAND AND WALES UNDER COMPANY NO 41424 OF (GB) | 2017-07-05 | — | — | EP | disclosed |
| US-9682028-B2 | Personal care photoprotective compositions with tricyclodecane amides | CONOPCO, INC. (US) | 2017-06-20 | — | — | US | disclosed |
| US-20160045419-A1 | PERSONAL CARE PHOTOPROTECTIVE COMPOSITIONS WITH TRICYCLODECANE AMIDES | CONOPCO, INC., D/B/A UNILEVER (US) | 2016-02-18 | — | — | US | disclosed |
| US-20160045419-A1 | PERSONAL CARE PHOTOPROTECTIVE COMPOSITIONS WITH TRICYCLODECANE AMIDES | CONOPCO, INC., D/B/A UNILEVER (US) | 2016-02-18 | — | — | US | disclosed |
| US-20160015616-A1 | PROLONGED DELIVERY OF CERTAIN FRAGRANCE COMPONENTS FROM PERSONAL CARE COMPOSITIONS | CONOPCO, INC., D/B/A UNILEVER (US) | 2016-01-21 | — | — | US | disclosed |
| US-20160015616-A1 | PROLONGED DELIVERY OF CERTAIN FRAGRANCE COMPONENTS FROM PERSONAL CARE COMPOSITIONS | CONOPCO, INC., D/B/A UNILEVER (US) | 2016-01-21 | — | — | US | disclosed |
| US-20160008249-A1 | COSMETIC COMPOSITIONS WITH TRICYCLODECANE AMIDES | CONOPCO, INC., D/B/A UNILEVER (US) | 2016-01-14 | — | — | US | disclosed |
| US-20160008249-A1 | COSMETIC COMPOSITIONS WITH TRICYCLODECANE AMIDES | CONOPCO, INC., D/B/A UNILEVER (US) | 2016-01-14 | — | — | US | disclosed |
| WO-2015086428-A1 | PROCESS OF MAKING ADAMANTANAMIDES | UNILEVER PLC (GB) | 2015-06-18 | — | — | WO | disclosed |
| WO-2014139952-A2 | PROLONGED DELIVERY OF CERTAIN FRAGRANCE COMPONENTS FROM PERSONAL CARE COMPOSITIONS | UNILEVER PLC (GB) | 2014-09-18 | — | — | WO | disclosed |
| WO-2014139965-A1 | PHOTOPROTECTIVE COMPOSITIONS WITH TRICYCLODECANE AMIDES | UNILEVER PLC (GB) | 2014-09-18 | — | — | WO | disclosed |
| WO-2014139963-A1 | COSMETIC COMPOSITIONS WITH TRICYCLODECANE AMIDES | UNILEVER PLC (GB) | 2014-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160015616-A1 | PROLONGED DELIVERY OF CERTAIN FRAGRANCE COMPONENTS FROM PERSONAL CARE COMPOSITIONS | DPM1, DHCR24, POLR1C | MAPK1 2835/4885HSD11B1 598/4885L3MBTL1 874/4885 |
| US-20160045419-A1 | PERSONAL CARE PHOTOPROTECTIVE COMPOSITIONS WITH TRICYCLODECANE AMIDES | CUTA, ERCC1, ERCC5 | MAPK1 4052/4885HSD11B1 2035/4885L3MBTL1 4223/4885 |
| US-20160008249-A1 | COSMETIC COMPOSITIONS WITH TRICYCLODECANE AMIDES | CUTA, ACMSD, LAGE3 | MAPK1 3658/4885HSD11B1 1684/4885L3MBTL1 4115/4885 |
| US-20220111367-A1 | HYDROGENATION CATALYST FOR USE IN HYDROGENATING AMIDE COMPOUND AND METHOD FOR PRODUCING AMINE COMPOUND USING SAME | SUV39H2, SUV39H1, HRH3 | MAPK1 3891/4885HSD11B1 2358/4885L3MBTL1 4666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.